Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Takenao Hasegawa"'
Publikováno v:
Nutrition (Burbank, Los Angeles County, Calif.). 31(6)
Publikováno v:
Alimentary Pharmacology & Therapeutics. 15:1667-1672
Background Non-alcoholic steatohepatitis is a distinct entity, characterized by fatty change, lobular inflammation and fibrosis of the liver. Some cases of non-alcoholic steatohepatitis progress to cirrhosis, but it is not easy to distinguish this di
Autor:
Hiroyuki Harada, Masashi Yoneda, Takeshi Kyouda, Yoshikazu Yoshida, Kuniyo Ohnishi, Kimihide Nakamura, Takenao Hasegawa, Isao Makino
Publikováno v:
Journal of Gastroenterology and Hepatology. 13:1201-1206
Dumping syndrome commonly occurs after gastrectomy. The late dumping, which is one of the dumping syndromes, is due to postprandial hypoglycaemia caused by an excessive insulin secretion after a sharp rise in plasma glucose. Several treatments, inclu
Autor:
TAKENAO HASEGAWA, MASASHI YONEDA, KIMIHIDE NAKAMURA, KUNIYO OHNISHI, HIROYUKI HARADA, TAKESHI KYOUDA, YOSHIKAZU YOSHIDA, ISAO MAKINO
Publikováno v:
Journal of Gastroenterology and Hepatology. 13:1201-1206
Autor:
Keisuke Tamori, Takenao Hasegawa, Shiro Yokohama, Masaru Aoshima, Masanori Fujita, H. Saito, Kimura A, T. Kato, Masashi Yoneda, Yoichi Sato, Isao Makino, Kimihide Nakamura
Publikováno v:
Journal of Gastroenterology and Hepatology. 11:385-390
The present study was undertaken in order to investigate the influence of ursodeoxycholic acid (UDCA) on the composition of sulfate-conjugated bile acids in the serum and urine of patients with chronic active hepatitis and compensated liver cirrhosis
Autor:
Masakazu Haneda, Mituyoshi Okada, Kazunobu Aso, Takenao Hasegawa, Masashi Yoneda, Satoshi Okamoto, Naoyuki Miyokawa, Yoshihiko Tokusashi, Shiro Yokohama, Kimihide Nakamura
Publikováno v:
Hepatology (Baltimore, Md.). 40(5)
The therapeutic efficacy of angiotensin II receptor antagonist, losartan, was studied in patients with nonalcoholic steatohepatitis (NASH). Seven patients with both NASH and hypertension were treated with losartan (50 mg/d) for 48 weeks. Treatment wi
Autor:
Shiro Yokohama, Masashi Yoneda, Yoichi Sato, Takenao Hasegawa, Keisuke Tamori, Isao Makino, Kazunobu Aso, Masaru Aoshima, Kimihide Nakamura
Publikováno v:
Journal of gastroenterology and hepatology. 13(5)
Ursodeoxycholic acid (UDCA) has been shown to have beneficial effects on patients with primary biliary cirrhosis, suggesting that UDCA has immunomodulating effects. We investigated the effect of UDCA in patients with autoimmune hepatitis (AIH) which
Autor:
Isao Makino, Takenao Hasegawa
Publikováno v:
Journal of gastroenterology. 30(1)
Biliary apolipoprotein A1 in bile inhibits the nucleation of cholesterol crystals from bile super-saturated with cholesterol. In the present study, using an enzyme-linked immunosorbent assay of apolipoprotein A1, we determined the content of apolipop
Autor:
Takenao Hasegawa, Masakazu Haneda, Masashi Yoneda, Satoshi Okamoto, Kazunobu Aso, Yoshihiko Tokusashi, Kimihide Nakamura, Naoyuki Miyokawa, Shiro Yokohama, Yosui Tamaki, Mituyoshi Okada, Masaru Aoshima
Publikováno v:
World Journal of Gastroenterology. 12:322
AIM: To investigate the efficacy of angiotensin II receptor antagonist on hepatic stellate cells (HSCs) activation in the patients with non-alcoholic steatohepatitis (NASH). METHODS: Seven patients with NASH were prescribed losartan, a selective angi
Publikováno v:
Hepatology. 39:568-568